Search research articles
Contact Us
Filters
Showing results (231-240 of 298) with videos related to
Page
of 30
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 15, 2025
ALT Is an Effective Screening Tool for Advanced Metabolic Dysfunction-Associated Steatotic Liver Disease in Children With Obesity and Overweight
Anne-Sophie R Stroes, Laura Draijer, Malika Chegary, et al.
The Lancet. Gastroenterology & Hepatology
|
May 20, 2017
Peg-interferon plus nucleotide analogue treatment versus no treatment in patients with chronic hepatitis B with a low viral load: a randomised controlled, open-label trial
Annikki de Niet, Louis Jansen, Femke Stelma, et al.
Hepatology International
|
October 4, 2016
Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge
Serge J Zweers, Elisabeth M de Vries, Martin Lenicek, et al.
JHEP Reports : Innovation in Hepatology
|
February 11, 2020
Endoscopic duodenal mucosal resurfacing improves glycaemic and hepatic indices in type 2 diabetes: 6-month multicentre results
Annieke C G van Baar, Ulrich Beuers, Kari Wong, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
November 20, 2024
Outcome of a 'step-up approach' for recurrent cholangitis in patients with a non-stenotic hepaticojejunostomy after hepato-pancreato-biliary surgery: single center series
Alessandro M Bonomi, Anouk G Overdevest, Jeska A Fritzsche, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 7, 2014
Characterization and treatment of persistent hepatocellular secretory failure
Remco van Dijk, Andreas E Kremer, Wouter Smit, et al.
JHEP Reports : Innovation in Hepatology
|
July 9, 2024
Corrigendum to: "Endoscopic duodenal mucosal resurfacing improves glycaemic and hepatic indices in type 2 diabetes: 6-month multicentre results" [JHEP Reports 5 (2019) 101041]
Annieke C G van Baar, Ulrich Beuers, Kari Wong, et al.
Hepatology (Baltimore, Md.)
|
February 3, 2015
Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na(+) -taurocholate cotransporting polypeptide knockout mice
Davor Slijepcevic, Christina Kaufman, Catharina G K Wichers, et al.
Shock (Augusta, Ga.)
|
July 9, 2021
Incidence, Clinical Characteristics and Outcomes of Early Hyperbilirubinemia in Critically Ill Patients: Insights From the MARS Study
Jenny Juschten, Lieuwe D J Bos, Harm-Jan de Grooth, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 17, 2015
Risk factors for primary sclerosing cholangitis
Kirsten Boonstra, Elisabeth M G de Vries, Nan van Geloven, et al.
Page
of 30
Search research articles
Search
Showing results (231-240 of 298) with videos related to
Sort By:
Page
of 30
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 15, 2025
ALT Is an Effective Screening Tool for Advanced Metabolic Dysfunction-Associated Steatotic Liver Disease in Children With Obesity and Overweight
Anne-Sophie R Stroes, Laura Draijer, Malika Chegary, et al.
The Lancet. Gastroenterology & Hepatology
|
May 20, 2017
Peg-interferon plus nucleotide analogue treatment versus no treatment in patients with chronic hepatitis B with a low viral load: a randomised controlled, open-label trial
Annikki de Niet, Louis Jansen, Femke Stelma, et al.
Hepatology International
|
October 4, 2016
Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge
Serge J Zweers, Elisabeth M de Vries, Martin Lenicek, et al.
JHEP Reports : Innovation in Hepatology
|
February 11, 2020
Endoscopic duodenal mucosal resurfacing improves glycaemic and hepatic indices in type 2 diabetes: 6-month multicentre results
Annieke C G van Baar, Ulrich Beuers, Kari Wong, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
November 20, 2024
Outcome of a 'step-up approach' for recurrent cholangitis in patients with a non-stenotic hepaticojejunostomy after hepato-pancreato-biliary surgery: single center series
Alessandro M Bonomi, Anouk G Overdevest, Jeska A Fritzsche, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 7, 2014
Characterization and treatment of persistent hepatocellular secretory failure
Remco van Dijk, Andreas E Kremer, Wouter Smit, et al.
JHEP Reports : Innovation in Hepatology
|
July 9, 2024
Corrigendum to: "Endoscopic duodenal mucosal resurfacing improves glycaemic and hepatic indices in type 2 diabetes: 6-month multicentre results" [JHEP Reports 5 (2019) 101041]
Annieke C G van Baar, Ulrich Beuers, Kari Wong, et al.
Hepatology (Baltimore, Md.)
|
February 3, 2015
Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na(+) -taurocholate cotransporting polypeptide knockout mice
Davor Slijepcevic, Christina Kaufman, Catharina G K Wichers, et al.
Shock (Augusta, Ga.)
|
July 9, 2021
Incidence, Clinical Characteristics and Outcomes of Early Hyperbilirubinemia in Critically Ill Patients: Insights From the MARS Study
Jenny Juschten, Lieuwe D J Bos, Harm-Jan de Grooth, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 17, 2015
Risk factors for primary sclerosing cholangitis
Kirsten Boonstra, Elisabeth M G de Vries, Nan van Geloven, et al.
Page
of 30